Preclinical Characterization of the Radioimmunoconjugate <sup>111</sup>In or <sup>90</sup>Y-FF-21101 Against a P-Cadherin–Expressing Tumor in a Mouse Xenograft Model and a Nonhuman Primate
The Journal of nuclear medicine